UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

Cancer cell, 2015-11, Vol.28 (5), p.666-676

2015

Volltextzugriff (PDF)

KLIFS: an overhaul after the first 5 years of supporting kinase research

Nucleic acids research, 2021-01, Vol.49 (D1), p.D562

2021

Volltextzugriff (PDF)

The Landscape of Atypical and Eukaryotic Protein Kinases

Trends in pharmacological sciences (Regular ed.), 2019-11, Vol.40 (11), p.818-832

2019

Volltextzugriff (PDF)

p120-catenin-dependent collective brain infiltration by glioma cell networks

Nature cell biology, 2020-01, Vol.22 (1), p.97

2020

Volltextzugriff (PDF)

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

Nature (London), 2012-03, Vol.483 (7391), p.589-593

2012

Volltextzugriff (PDF)

Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms

Journal of medicinal chemistry, 2023-06, Vol.66 (11), p.7253-7267

2023

Volltextzugriff (PDF)

A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions

Clinical cancer research, 2024-04, Vol.30 (8), p.1685

2024

Volltextzugriff (PDF)

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather

European journal of nuclear medicine and molecular imaging, 2022-01, Vol.49 (2), p.481-491

2022

Volltextzugriff (PDF)

Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks

PLoS computational biology, 2023-09, Vol.19 (9), p.e1011301-e1011301

2023

Volltextzugriff (PDF)

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

BMC cancer, 2017-03, Vol.17 (1), p.204, Article 204

2017

Volltextzugriff (PDF)

ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome

Cancer cell, 2009-04, Vol.15 (4), p.328-340

2009

Volltextzugriff (PDF)

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

Drug resistance updates, 2019-03, Vol.43, p.29-37

2019

Volltextzugriff (PDF)

Review: A Roadmap to Use Nonstructured Data to Discover Multitarget Cancer Therapies

JCO clinical cancer informatics, 2023-04, Vol.7, p.e2200096

2023

Volltextzugriff (PDF)

Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation

Cell reports (Cambridge), 2017-10, Vol.21 (3), p.823-833

2017

Volltextzugriff (PDF)

Oncogenic composite mutations can be predicted by co-mutations and their chromosomal location

Molecular oncology, 2024-05

2024

Volltextzugriff (PDF)

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

Anticancer research, 2019-07, Vol.39 (7), p.3303-3309

2019

Volltextzugriff (PDF)

GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors

PloS one, 2012-05, Vol.7 (5), p.e35943-e35943

2012

Volltextzugriff (PDF)

Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer

The Journal of clinical investigation, 2012-05, Vol.122 (5), p.1920-1932

2012

Volltextzugriff (PDF)

WINDOW consortium: A path towards increased therapy efficacy against glioblastoma

Drug resistance updates, 2018-09, Vol.40, p.17-24

2018

Volltextzugriff (PDF)

Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures

Neuro-oncology advances, 2023-01, Vol.5 (1), p.vdad134-vdad134

2023

Volltextzugriff (PDF)

Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies

Neuro-oncology advances, 2023-01, Vol.5 (1), p.vdad073-vdad073

2023

Volltextzugriff (PDF)

Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma

Molecular cancer therapeutics, 2018-02, Vol.17 (2), p.347-354

2018

Volltextzugriff (PDF)

Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions

Journal for immunotherapy of cancer, 2023-12, Vol.11 (12), p.e007631

2023

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(70)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

KLIFS: an overhaul after the first 5 years of supporting kinase research

The Landscape of Atypical and Eukaryotic Protein Kinases

Neuroblastoma is composed of two super-enhancer-associated differentiation states

p120-catenin-dependent collective brain infiltration by glioma cell networks

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms

A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather

Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

Review: A Roadmap to Use Nonstructured Data to Discover Multitarget Cancer Therapies

Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation

Oncogenic composite mutations can be predicted by co-mutations and their chromosomal location

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors

Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer

WINDOW consortium: A path towards increased therapy efficacy against glioblastoma

Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures

Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies

Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma

Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8

Suchergebnisse filtern